Grifols currently manufactures the solution in Murcia, Spain. In 2017, Grifols received FDA approval to market its normal saline solution in 500 milliliter polypropylene bags in the U.S. to mitigate the current shortage of normal saline in the U.S.
This agreement represents a step to further develop Grifols’ hospital division in the U.S., a key market for the division growth strategy.
More articles on supply chain:
4 things to know about BostonSight’s new CMO Dr. Daniel Brooks
Medial EarlySign secures $30M in series B funding — 3 insights
Takeda constructing modular cell therapy facility in Dublin
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
